Institut Du Cancer De Montpellier - Val D'aurelle
Clinical trials sponsored by Institut Du Cancer De Montpellier - Val D'aurelle, explained in plain language.
-
Can a radiation boost stop breast cancer from coming back?
Disease control OngoingThis large study is testing whether adding an extra, focused dose of radiation to the tumor site helps prevent cancer from returning in women with a very early form of breast cancer called DCIS. All participants had surgery to remove the cancer followed by standard whole-breast r…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for End-Stage colon cancer patients in major drug trial
Disease control OngoingThis study is for people with advanced colorectal cancer that has spread and has stopped responding to all standard treatments. It compares two approaches: taking the drug regorafenib alone versus taking regorafenib combined with another drug called irinotecan. The main goal is t…
Phase: PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New tracking tech aims to reduce radiation side effects for prostate cancer patients
Disease control OngoingThis study is testing whether a newer, more precise radiation tracking system causes fewer long-term side effects in the pelvic area compared to standard radiation for prostate cancer. Men with low- or intermediate-risk prostate cancer will be randomly assigned to receive radiati…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Aerosol chemo trial aims to extend life for inoperable cancer patients
Disease control TerminatedThis study is testing whether adding a new pressurized aerosol chemotherapy (PIPAC) directly into the abdomen, along with standard intravenous chemotherapy, works better than standard IV chemo alone for people with advanced peritoneal mesothelioma who cannot have surgery. The mai…
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New test could spare thyroid patients unnecessary surgery
Diagnosis OngoingThis study aims to validate a new molecular test to better determine if thyroid nodules are cancerous. It involves 71 patients with inconclusive biopsy results. The goal is to improve diagnosis so fewer people undergo surgery for benign nodules.
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Yoga breakthrough eases trauma for women in cancer isolation
Symptom relief OngoingThis study is testing whether a special program combining physiotherapy, yoga, and patient education can help reduce stress and pain for women undergoing a specific radiation treatment (brachytherapy) for cervical cancer. The treatment requires strict bed rest in isolation, which…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC